Get startedLog in
    Picture of Phaxiam Therapeutics SA logo

    PHXM — Phaxiam Therapeutics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Erytech Granted U.S. FDA Fast Track Designation For Eryaspase In Second-Line Pancreatic Cancer

    Picture of Phaxiam Therapeutics SA logoPhaxiam Therapeutics SA
    29/04/2020 01:36
    April 28 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH GRANTED U.S. FDA FAST TRACK DESIGNATION FOR
ERYASPASE IN
SECOND-LINE PANCREATIC CANCER

Source text for Eikon:  ID:nGNXRYLDd 
Further company coverage:  ERYP.PA 

 (Reuters.Briefs@thomsonreuters.com)

    Recent news on Phaxiam Therapeutics SA

    See all news